Canadian Cancer Trials Group Bulletins

Trial Management Group


Trial Activation

Canadian Cancer Trials Group BR.26 -- A Double-Blind Placebo Controlled Randomized Trial of PF-804 in Patients with Incurable Stage IIIB/IV Non-Small Cell Lung Cancer After Failure of Standard Therapy for Advanced or Metastatic Disease -- was centrally activated 4 September 2009.

http://www.ctg.queensu.ca/trials/lung/br26/br26.html